Fungal infection overview.
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001759:Blastomycosis / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D002180:Candidiasis, Oral / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D002181:Candidiasis, Vulvovaginal / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D003022:Clotrimazole / Q000627:therapeutic use; D015725:Fluconazole / Q000627:therapeutic use; D006660:Histoplasmosis / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D016919:Meningitis, Cryptococcal / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D009181:Mycoses / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*
D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole; D003022:Clotrimazole